Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB06414_DB08865_nanopub.RAeqG7Il1GLqXRo-rh594969Q0EcGUffeQ1acMsjzlrAg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB06414_DB08865 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB06414_DB08865 label "DDI between Etravirine and Crizotinib - Crizotinib, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to avoid this combination. [drugbank_resource:DB06414_DB08865]" assertion.
- drugbank_resource:DB06414_DB08865 identifier "drugbank_resource:DB06414_DB08865" assertion.
- drugbank_resource:DB06414_DB08865 title "DDI between Etravirine and Crizotinib - Crizotinib, when administered concomitantly with etravirine (a strong CYP3A4 inducer), may experience a decrease in serum concentration. It is recommended to avoid this combination." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06414_DB08865 assertion.
- drugbank:DB08865 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB06414_DB08865 assertion.